-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322. Disorders of Coagulation or Fibrinolysis: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, antibodies, Biological, Bleeding Disorders, Coronaviruses, Hemophilia, SARS-CoV-2/COVID-19, Bleeding and Clotting, Diseases, Hemostasis, Non-Biological, Combinations, Therapies, Genetic Disorders, Pediatric, Biological Processes, coagulant drugs, iron deficiency, devices, Platelet Disorders, Young Adult, Protein Disorders, infusion, Study Population, Clinically relevant, transfusion, iron metabolism, VWD, pathways
Monday, December 7, 2020: 7:00 AM-3:30 PM

Aijing Shang, MD, PhD1*, Nives Selak Bienz1*, Ravi Gadiraju1*, Tiffany Chang2 and Peter Kuebler2*

1F. Hoffmann-La Roche Ltd, Basel, Switzerland
2Genentech, Inc., South San Francisco, CA

Jonathan R Day, MD, PharmD1*, Ashwin Gupta2, Calvin Abro, MD3*, Kyungsuk Jung, MD, MPH3*, Lakshmanan Krishnamurti, MD4,5, Clifford Takemoto, MD6* and Ruchika Goel, MD, MPH3,7

1Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA
2Vanderbilt University, Nashville, TN
3Division of Hematology/Oncology, Simmons Cancer Institute, SIU School of Medicine, Springfield, IL
4Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
5Emory Healthcare, Atlanta, GA
6Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
7Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD

Elizabeth Federici, MD, Matthew Evans, MD, Charles E Dye, MD* and M. Elaine Eyster, MD

Pennsylvania State University Milton S. Hershey Medical Center, Hershey, PA

Genevieve Moyer, MD, MSc1 and Patricia Huguelet, MD2,3*

1Hematology, University of Colorado Hospital, Denver, CO
2Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora
3Obstetrics and Gynecology, Children's Hospital Colorado, Aurora

Lucy Emma Rosenbaum, MD1*, Ayesha Zia2, Joseph R Stanek, MS3*, Fareeda W. Haamid, DO4, Myra Christian-Rancy, BS1*, Nicole Kendel, MD5* and Sarah H. O'Brien, MD6

1Nationwide Children's Hospital, Columbus, OH
2University of Southwestern Medical Center, Dallas, TX
3Division of Biostatistics, Nationwide Children's Hospital, Columbus, OH
4Department of Pediatrics, Division of Adolescent Medicine, The Ohio State University College of Medicine, Nationwide Children’s Hospital, Columbus, OH
5Department of Hematology and Oncology, Nationwide Children's Hospital, Columbus, OH
6Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, Nationwide Children's Hospital, Columbus, OH

Daria V Madeeva, MD1*, Jana Christian, MD2*, George Goshua, MD3, Hyung J. Chun, MD4*, Alfred Ian Lee, MD, PhD5 and Alexander B Pine, MD, PhD6

1Yale New Haven Hospital, New Haven, CT
2Department of Medicine, Yale University School of Medicine, New Haven, CT
3Section of Hematology, Yale University School of Medicine, New Haven, CT
4Department of Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT
5Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
6Department of Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT

Bilgimol Chumappumkal Joseph, PhD1 and Annette von Drygalski, MD, Pharm D2,3

1University of California, San Diego, CA
2Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA
3Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA

Maria Helena Podolak-Dawidziak, professor1*, Janusz Zawilski2*, Mariola Bober2*, Ewa Stefanska-Windyga, MD, PhD3*, Anna Buczma, MD4* and Iwona Prajs, PhD1*

1Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wroclaw, Poland
2INTERLAB, Poznan, POL
3Institute of Haematology and Transfusion Medicine, Warsaw, Poland
4Institute of Hematology and Blood Transfusion, Warsaw, Poland

Claude Négrier1, Margaret V. Ragni, MD, MPH2, John Pasi, MB, ChB, PhD, FRCP, FRCPath, FRCPCH3, Steven W. Pipe, MD4, Gili Kenet5, Savita Rangarajan, MBBS, MD, FRCP, FRCPath6, Salim Kichou7*, Baisong Mei7 and Shauna R. Andersson7*

1Hôpital Cardiologique Louis Pradel, Lyon, France
2Department of Medicine - Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA
3Royal London Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom
4Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI
5Israel National Hemophilia Center and Thrombosis Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
6Guy's & St. Thomas' NHS Foundation Trust, Basingstoke, ENG, United Kingdom
7Sanofi, Cambridge, MA

Genevieve Moyer, MD, MSc1 and Patricia Huguelet, MD2,3*

1Hematology, University of Colorado Hospital, Denver, CO
2Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora
3Obstetrics and Gynecology, Children's Hospital Colorado, Aurora

Courtney D Thornburg, MD1,2, Kenneth D Friedman, MD3, Michael F Guerrera, MD4, Chunla He5*, Lynn M Malec, MD3, Mindy L Simpson, MD6, Michael D Tarantino, MD7, H. Marijke Van Den Berg3*, Crystal Watson, BS5* and Shannon L Carpenter, MD8

1UC San Diego, La Jolla, CA
2Rady Children's Hospital, San Diego, CA
3Versiti BloodCenter of Wisconsin, Milwaukee, WI
4Children's National Hospital, Washington, DC
5American Thrombosis and Hemostasis Network, Rochester, NY
6Rush University Medical Center, Chicago, IL
7The Bleeding & Clotting Disorders Institute, Peoria, IL
8Children's Mercy Kansas City, Kansas City, MO

Amy D Shapiro, MD1, Giancarlo Castaman, MD2*, Katarina Cepo, MD3*, Sidsel Marie Tønder, MSc4*, Tadashi Matsushita, MD, PhD5, Lone Hvitfeldt Poulsen6*, Guy Young, MD7, Silva Zupancic-Šalek, MD8* and Victor Jimenez Yuste, MD, PhD9*

1Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
2Azienda Ospedaliera Universitaria Careggi, Florence, Italy
3Biopharm Medical & Science, Novo Nordisk A/S, Søborg, Denmark
4Biostatistics Biopharm 1, Novo Nordisk A/S, Søborg, Denmark
5Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan
6The Haemophilia Centre, Department of Haematology, Aarhus University, Aarhus, Denmark
7Keck School of Medicine, University of Southern California, Los Angeles, CA
8Department of Hemostasis, Thrombosis and Non-Aligned Hematology, Hematology Institute Zagreb, Zagreb, Croatia
9Haematology Department, La Paz University Hospital, Madrid, Spain

Steven W. Pipe, MD1, Michael Recht, MD, PhD2, Michael U. Callaghan, MD3, Robert F. Sidonio Jr., MD, MSc.4, Jerry Grandoni, PhD5*, Veronique Duretz6*, Daniel Bonzo, PhD5*, Jean Luc Plantier, PhD7*, Sean Evans, PhD, RPh5*, Ian S Mitchell, PhD8* and Cedric Hermans, MD, MRCP, PhD9

1Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI
2American Thrombosis and Hemostasis Network, Rochester, NY
3Children's Hospital of Michigan, Detroit, MI
4Aflac Cancer and Blood Disorders and Emory University, Atlanta, GA
5LFB, Framingham, MA
6LFB, Lille, France
7LFB, Loos, France
8GLOVAL, LLC, Lafayette, CO
9Cliniques Univ. Saint-Luc, Brussels, Belgium

Dimitrios A. Tsakiris, MD1*, Johannes Oldenburg2*, Robert Klamroth, MD, PhD3*, Benoît Guillet4*, Kate Khair5*, Angela Huth-Kühne, MD6*, Karin Kurnik7*, Stephan Regensburger8*, Jaco Botha9*, Alejandro Fernandez9*, Leilei Tang9* and Margareth C. Ozelo10

1Diagnostic Hematology, University Hospital Basel, Basel, Switzerland
2Institute of Experimental Hematology and Transfusion Medicine, Bonn University Clinic, Bonn, Germany
3Department for Internal Medicine, Vascular Medicine and Haemostaseology, Vivantes Klinikum im Friedrichshain, Berlin, Germany
4Hemophilia Treatment Centre, Inserm U1085 IRSET, University Hospital of Rennes, Rennes, France
5Centre for Outcomes and Experience Research in Children’s Health, Illness and Disability (ORCHID), Great Ormond Street Hospital for Children, London, United Kingdom
6SRH Kurpfalzkrankenhaus and Haemophilia Centre Heidelberg GmbH, Heidelberg, Germany
7Dr. von Haunersches Kinderspital Klinikum der Universität München, Munich, Germany
8Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany
9Takeda Pharmaceutical International AG, Zürich, Switzerland
10Hemocentro UNICAMP, University of Campinas, Campinas, Brazil

Janna M. Journeycake, MD1, Cedric Hermans, MD, MRCP, PhD2, Jonathan M. Ducore, MD, MPH3, Miguel A. Escobar, M.D.4*, Guy Young, MD5, Michael Wang, MD6, Doris Quon, MD, PhD7, W Allan Alexander, MD8*, Ian S Mitchell, PhD9*, Ahmad Al-Sabbagh, MD10* and Daniel Bonzo, PhD10*

1Jimmy Everest Center for Cancer and Blood Disorders, University of Oklahoma Health Sciences Center, Oklahoma City, OK
2Cliniques Univ. Saint-Luc, Brussels, Belgium
3Hemostasis and Thrombosis Center, UC Davis, Sacramento, CA
4University of Texas Health Science Center, Houston, TX
5University of Califormia Los Angeles, Children's Hospital Los Angeles, Los Angeles, CA
6Hemophilia and Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora, CO
7Orthopaedic Institute for Children, Los Angeles, CA
8HEMA Biologics, Louisville, KY
9GLOVAL, LLC, Lafayette, CO
10LFB, Framingham, MA

Craig D. Seaman1, Margaret V. Ragni, MD, MPH2, Jonathan G. Yabes, PhD3* and Christina Lalama3*

1University of Pittsburgh, Warrendale, PA
2Department of Medicine - Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA
3Center for Research on Health Care Data Center, University of Pittsburgh, Pittsburgh, PA

Trine Høyer Rose, PhD*, Christian Hollensen, MSc, PhD*, Henrik Agersø, DVM, PhD* and Rune Viig Overgaard, PhD*

Quantitative Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark

François Stephan1*, Laure Gutermann1*, Martine Pennetier2*, Stephanie Bourget3*, Sarah Djabarouti4*, Johanna Berdugo5*, Yann Fardini6*, Pierre Clerson6* and Bruce A. Schwartz, PhD7

1Hôpital Marie Lannelongue, Le Plessis Robinson, France
2Hôtel Dieu, Pharmacie Clinique, Nantes, France
3Centre Hospitalier de Valence, Valence, France
4Groupe Hospitalier Sud, CHU de Bordeaux, Pessac, France
5Hôpital Saint-Joseph, Marseille, France
6Soladis Clinical Studies, Roubaix, France
7Octapharma US, Atlantic City, NJ

Anne Flem Jacobsen, MD1*, Joseph M Parker, MD2*, Diane Trybul, BS2* and Per Morten Sandset, MD3

1Oslo University Hospital, Oslo, Norway
2Prometic Biotherapeutics, Rockville, MD
3Department of Haematology and Research Institute of Internal Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway

Mark Reding, MD1, Thomas Moulton, MD2, Erika Soltes Rak2* and Mindy L Simpson, MD3

1Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN
2Bayer, Whippany, NJ
3Rush University Medical Center, Chicago, IL

*signifies non-member of ASH